Thanks for the info again, always appreciate your expertise/well...

Thanks for the info again, always appreciate your expertise/well researched thoughts on some of the medical product and consumables area.

I was an Analytica shareholder a few years back, and thankfully sold out following their transition towards the pericoach device, so have kept a constant eye on developments there. It's a shame how things have worked out and a lesson for those bringing new developments to market, that even though you may have a superior product, it is no sure thing and very dependent on being in the right place at the right time, luck, management and regulations/acceptance. With that said, I like MLA's approach to licensing proven products. It seems to be a risk free way of obtaining a good stable of offerings without the added disadvantage of signifcant R&D. Although the upside is also slightly more limited.


Agree on the economics aspect of acquiring the burette, It's likely won't stack up given current sales. It would only make sense if there was increasing interest/significant sales on the horizon. Its a shame that area seems to have fallen quiet after some of the traction made a few years back in training hospitals etc.


Bring on the next quarterly report..!



DYOR, IMO etc....